HomepageMedicineIDEAYA Names Stu Dorman as New Chief Commercial Officer Medicine IDEAYA Names Stu Dorman as New Chief Commercial Officer admin Posted on November 22, 2024 Dorman previously served as head of Gilead Sciences’ U.S. Oncology Unit. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostLitter Robot 4 Review 2024: How It Measured Up in My Multi-Cat Home Next PostHow to Plan a Family Heritage Trip You Might Also Like Medicine FDA Approves Novartis' Lutathera for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors admin April 24, 2024 Medicine Jelmyto Demonstrates Significant Recurrence-Free Survival Rate at Three Years in Patients with Low-Grade Upper Tract Urothelial Cancer admin January 24, 2025 Medicine How Diverse Skills Can Drive Success in Biotech admin May 6, 2024 Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin April 4, 2024
Medicine FDA Approves Novartis' Lutathera for Pediatric Patients with Gastroenteropancreatic Neuroendocrine Tumors admin April 24, 2024
Medicine Jelmyto Demonstrates Significant Recurrence-Free Survival Rate at Three Years in Patients with Low-Grade Upper Tract Urothelial Cancer admin January 24, 2025
Medicine FDA Approves Vanda Pharmaceuticals' Fanapt to Treat Adults with Bipolar I Disorder admin April 4, 2024